Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Craniofac Surg ; 30(6): 1734-1737, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31205275

RESUMO

BACKGROUND: Cranial vault surgeries are invasive, extensive procedures with blood transfusions being frequently required. Previous interventions have been described to attempt to decrease the transfusion burden. The objective of this study is to determine if a Pediatric Blood Management (PBM) team can reduce transfusion requirements in children undergoing cranial vault surgery. METHODS: A protocol was developed which involved preoperative optimization of hemoglobin (Hb), intraoperative use of tranexamic acid, cell saver technology, and blood sparing operative techniques. Patients were preoperatively screened with basic laboratory testing. Retrospective data on 20 consecutive patients who underwent craniofacial surgery prior were used as controls. Prospective data on patients was collected. RESULTS: Groups were similar in age and weight. Postoperative Hb measurements were similar, with the control group 10.9 ±â€Š2.2 g/dL and the intervention arm 9.6 + 2.7 g/dL. Discharge Hb concentrations also were similar with 9.6 ±â€Š1.6 g/dL and 9.7 ±â€Š2.5 g/dL in the control and PBM group, respectively. The rate of transfusion decreased from 80% to 42% after protocol implementation (P = 0.007). During the last 6 months of data collection, the transfusion rate decreased further to 17%. Furthermore, 4 patients were found to have von Willebrand disease preoperatively with only 1 requiring a transfusion. CONCLUSIONS: The authors found that the institution of a PBM team reduced the transfusion burden of patients, including complex patients with von Willebrand disease. The use of a multimodal approach to hematologic management optimized patients for their procedures and helped minimize exposure to transfusion associated complications.


Assuntos
Crânio/cirurgia , Transfusão de Sangue/estatística & dados numéricos , Criança , Humanos , Alta do Paciente , Período Pós-Operatório , Estudos Prospectivos , Procedimentos de Cirurgia Plástica/métodos , Estudos Retrospectivos
2.
J Pediatr Nurs ; 30(4): 598-610, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25450444

RESUMO

Hospital acquired pressure ulcers (HAPU) are serious, debilitating, and preventable complications in all inpatient populations. Despite evidence of the development of pressure ulcers in the pediatric population, minimal research has been done. Based on observations gathered during quarterly HAPU audits, bedside nursing staff recognized trends in pressure ulcer locations that were not captured using current pressure ulcer risk assessment tools. Together, bedside nurses and nursing leadership created and conducted multiple research studies to investigate the validity and reliability of the Pediatric Pressure Ulcer Prediction and Evaluation Tool (PPUPET).


Assuntos
Avaliação em Enfermagem , Úlcera por Pressão/prevenção & controle , Adolescente , Criança , Criança Hospitalizada , Feminino , Hospitais Pediátricos , Humanos , Masculino , Michigan/epidemiologia , Recursos Humanos de Enfermagem Hospitalar , Úlcera por Pressão/epidemiologia , Prevalência , Medição de Risco , Fatores de Risco
3.
J Assoc Nurses AIDS Care ; 18(3): 74-86, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17570302

RESUMO

The detection of resistance by HIV drug resistance assays has become an important management tool for use in the HIV-infected patient. Because of its important role in management of HIV disease, it is important for the nurse to understand the mechanism of HIV resistance, the appropriate use of resistance tests, and how to use this information to improve or maximize patient outcomes. The purpose of this review is to increase the nurse's awareness of the problem of resistance, to describe the available resistance tests, and to develop a model whereby the patient collaborates with the health care team in understanding, implementing, and monitoring resistance-related actions.


Assuntos
Fármacos Anti-HIV/farmacologia , Farmacorresistência Viral , Infecções por HIV/tratamento farmacológico , Testes de Sensibilidade Microbiana/métodos , Fármacos Anti-HIV/uso terapêutico , Monitoramento de Medicamentos , Genótipo , HIV/efeitos dos fármacos , HIV/genética , Infecções por HIV/enfermagem , Infecções por HIV/virologia , Humanos , Fenótipo , Guias de Prática Clínica como Assunto
4.
Child Adolesc Psychiatr Clin N Am ; 15(3): 693-715, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16797445

RESUMO

The adolescent at the end of life poses a unique combination of challenges resulting from the collision of failing health with a developmental trajectory meant to lead to attainment of personal independence. Because virtually all spheres of the dying adolescent's life are affected, optimal palliative care for these young persons requires a multidisciplinary team whose members have a good understanding of their complementary roles and a shared commitment to providing well-coordinated care. Members of the team include the physician (to initiate and coordinate palliative care management); the nurse (to work collaboratively with the physician and adolescent, especially through effective patient advocacy); the psychologist (to assess and manage the patient's neurocognitive and emotional status); the social worker (to assess and optimize support networks); the chaplain (to support the adolescent's search for spiritual meaning); and the child life specialist (to facilitate effective communication in preparing for death). A crucial area for dying adolescents is medical decision making, where the full range of combined support is needed. By helping the young person continue to develop personal autonomy, the multidisciplinary team will enable even the dying adolescent to experience dignity and personal fulfillment.


Assuntos
Estado Terminal , Comunicação Interdisciplinar , Equipe de Assistência ao Paciente , Adaptação Psicológica , Adolescente , Luto , Tomada de Decisões , Família/psicologia , Humanos , Papel do Profissional de Enfermagem , Apoio Social , Assistência Terminal
5.
J Assoc Nurses AIDS Care ; 13(1): 50-9, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-11828859

RESUMO

The key treatment goal for managing anemia in patients infected with HIV is to maintain an improved or normal hemoglobin level. Whenever possible, the identification and treatment of the underlying cause of anemia is the primary therapeutic strategy. After excluding other etiologies, the Nursing Guidelines Committee for Anemia in Patients With HIV Infection has recommended that patients with mild asymptomatic anemia (hemoglobin level = 1 g/dl below the lower limit of the normal range) receive nutritional support and more frequent screening. Recombinant human erythropoietin (epoetin alfa) therapy is an appropriate treatment option for patients with symptomatic mild anemia or moderate anemia (hemoglobin level = 2 g/dl below the lower limit of the normal range). An immediate blood transfusion may be required under specific instances for patients with severe anemia (hemoglobin level less than or equal to 8 g/dl).


Assuntos
Anemia/enfermagem , Anemia/virologia , Infecções por HIV/complicações , Adulto , Algoritmos , Anemia/sangue , Anemia/diagnóstico , Transfusão de Sangue , Criança , Árvores de Decisões , Eritropoetina/uso terapêutico , Objetivos , Hematócrito , Hemoglobinas/análise , Humanos , Programas de Rastreamento/métodos , Apoio Nutricional/métodos , Planejamento de Assistência ao Paciente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...